Click here to see a list of our past events.
You are invited to join us on Thursday, October 1, from 11:00am–12:00pm, when CDR Michael Banyas, USPHS, M.P.A., M.A., Health Specialist at the National Institute on Minority Health and Health Disparities (NIMHD), will visit Weill Cornell Medicine’s campus. NIMHD has a special interest in women’s health and solutions to address health disparities.
The session will take place at BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, and will also be available via Zoom.
During the session, CDR Banyas will provide an overview of NIMHD programs and funding opportunities, including:
- New and current funding programs
- Reauthorization highlights
- Application tips and suggestions
- Commercialization resources for applicants and awardees
This will be a great opportunity for WCM faculty, researchers, and members of the broader NYC scientific community to learn more about NIMHD resources.
Please register here.
If you have any questions, please reach out to Loren Busby, Director, BioVenture eLab, at lob4002@med.cornell.edu.
Do you have a project in need of funding? Are you interested in learning about engaging with industry partners?
James Bellush, Manager of Scientific Scouting, will be hosting weekly virtual office hours, every Friday from 11 a.m. to 1 p.m. to help Weill Cornell investigators support their ongoing translational research projects through industry sponsored research collaborations and grants.
Please use the link here to schedule your private meeting with James. Questions? Email james.bellush@cornell.edu.
You are invited to join the Weill Cornell Medicine community for Revolutionizing Healthcare with AI-Powered Devices, a showcase of digital health innovations and technologies.
This event is part of #AIWeekNY, a community-led festival organized by Pulse NYC that celebrates innovation across the AI ecosystem.
The following innovators and their AI-enabled technologies will be featured:
EmulatRx
An agentic AI platform that uses real-world patient data to support clinical trial design. Presented by Weishen Pan, PhD, Research Associate, Department of Population Health Sciences, Weill Cornell Medicine
WAV AI
An AI-based tool that analyzes sounds to detect fistula stenosis. Presented by Bobak Mosadegh, PhD, Associate Professor of Biomedical Engineering in Radiology and Director, Dalio Institute of Cardiovascular Imaging, Weill Cornell Medicine
Postpartum Depression Risk Prediction
An Epic-integrated clinical decision support tool that analyzes electronic health record data to identify pregnant patients at elevated risk for postpartum depression. Presented by Yiye Zhang, PhD, MS, Associate Professor of Population Health Sciences, Weill Cornell Medicine
Corneal Confocal Microscopy for Neurodegenerative Disease Detection
A noninvasive approach that uses corneal confocal microscopy to detect changes in the cornea’s small nerve fibers. Quantitative imaging and predictive analysis may offer an accessible biomarker for detecting and monitoring neurodegeneration. Presented by Rayaz A. Malik, MBChB, PhD, FRCP, Professor of Medicine, Weill Cornell Medicine–Qatar
Most life science companies don't fail because the science was wrong. They fail because no one validated the problem, the customer, or the market before spending years and millions building toward them. They fail because no one left the lab — or the pitch deck — long enough to find out whether the problem they were solving was real, or whether the customer they imagined actually existed.
This webinar, moderated by Dr. Donna Rounds, associate director of Business Development and Licensing, CTL at Weill Cornell, brings together three practitioners who have confronted this challenge from radically different vantage points:
- Audrey Beckman, partner and chief innovation officer at Boomerang Ventures, who evaluates and co-builds health tech companies
- Dave Saunders, product development advisor at AiM Medical Robotics, where an MRI-guided neurosurgery robot has just completed first-in-human trials
- Dr. Amir Goldan, associate professor and serial inventor of Prism-PET and NeuroTwain at Weill Cornell Medicine, who is navigating the leap from lab to market
Join us to find out more.
